NR 566 Week 4 Test Questions and Answers 100% Correct

NR 566 Week 4 Test Questions and Answers 100% CorrectNR 566 Week 4 Test Questions and Answers 100% CorrectNR 566 Week 4 Test Questions and Answers 100% CorrectNR 566 Week 4 Test Questions and Answers 100% Correct treatment of obesity: evaluation of phentermine/topiramate - ANSWER-Schedule IV drug indicated for chronic weight loss. Phetermine suppresses appetite which topirmate increses satiety. Most common side efrects are dry mouth, constipation, blurred vision, and numbness tingling. -serious effects are memory loss, concentration, HTN, tachycardia, hypoglycemia treatment of obesity: evaluation of phentermine/topiramate contraindications: - ANSWER-Glaucoma or hyperthyroid -Should not be given with MAOI. Stop MAOI 2 weeks before starting. -Carbonic anhydrase increases risk for metabolic acidosis -diuretics that are not K+ sparing increases risk for hyperkalemia Baseline data for phentermine - ANSWER-Cardiac assessment